[39] recently analyzed the genomic sequence of tumor samples to compare genomic variations in LARC with CRT in patients who had achieved a pCR to chemoradiation versus a poor response, and they found Daxx‐ZBTB22 mutations in poor responders but no mutation occurred in complete responders, indicating Daxx participates in oncogenesis and radiation resistance. Here, DAXX is linked to neoplasm.